NCCN Guidelines® Insights: Hematopoietic growth factors, version 1.2022: Featured updates to the NCCN Guidelines Guidelines


Authors: Griffiths, E. A.; Roy, V.; Alwan, L.; Bachiashvili, K.; Baird, J.; Cool, R.; Dinner, S.; Geyer, M.; Glaspy, J.; Gojo, I.; Hicks, A.; Kallam, A.; Kidwai, W. Z.; Kloth, D. D.; Kraut, E. H.; Landsburg, D.; Lyman, G. H.; Mahajan, A.; Miller, R.; Nachar, V.; Patel, S.; Patel, S.; Perez, L. E.; Poust, A.; Riaz, F.; Rosovsky, R.; Rugo, H. S.; Simon, S.; Vasu, S.; Wadleigh, M.; Westbrook, K.; Westervelt, P.; Berardi, R. A.; Pluchino, L.
Title: NCCN Guidelines® Insights: Hematopoietic growth factors, version 1.2022: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for Hematopoietic Growth Factors provide recommendations for the appropriate use of growth factors in the clinical management of febrile neutropenia (FN), chemotherapy-induced thrombocytopenia (CIT), and chemotherapy-induced anemia (CIA). Management and prevention of these sequelae are an integral part of supportive care for many patients undergoing cancer treatment. The purpose of these guidelines is to operationalize the evaluation, prevention, and treatment of FN, CIT, and CIA in adult patients with nonmyeloid malignancies and to enable the patient and clinician to assess management options for FN, CIT, and CIA in the context of an individual patient's condition. These NCCN Guidelines Insights provide a summary of the important recent updates to the NCCN Guidelines for Hematopoietic Growth Factors, with particular emphasis on the incorporation of a newly developed section on CIT.
Keywords: adult; antineoplastic agents; antineoplastic agent; neoplasm; neoplasms; palliative care; anemia; palliative therapy; interleukin 3; humans; human; hematopoietic cell growth factors
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 20
Issue: 5
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2022-05-01
Start Page: 436
End Page: 442
Language: English
DOI: 10.6004/jnccn.2022.0026
PUBMED: 35545171
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 June 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Blaine Geyer
    84 Geyer
Related MSK Work